Kyong-Ah Yoon Selected Research

Kyong-Ah Yoon Research Topics

Disease

21	Neoplasms (Cancer) 02/2024 - 01/2004
6	Lung Neoplasms (Lung Cancer) 04/2016 - 11/2006
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 05/2002
5	Adenocarcinoma of Lung 01/2021 - 04/2008
4	Breast Neoplasms (Breast Cancer) 05/2019 - 06/2009
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2021
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2019 - 04/2016
3	Stomach Neoplasms (Stomach Cancer) 01/2018 - 06/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012 - 03/2010
2	Adenocarcinoma 02/2024 - 01/2018
2	Cholangiocarcinoma 02/2023 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 04/2019
2	Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction) 01/2022 - 01/2021
2	Genomic Instability 10/2021 - 04/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2017 - 12/2016
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2017 - 01/2015
2	Microsatellite Instability 05/2009 - 05/2002
1	Sarcoma (Soft Tissue Sarcoma) 02/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Residual Neoplasm 01/2022
1	Transitional Cell Carcinoma 12/2021
1	Dysuria 12/2021
1	Thrombophilia 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Chromosomal Instability (Chromosome Stability) 05/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Mouth Neoplasms (Oral Cancer) 01/2018
1	Carcinogenesis 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2017
1	Neutropenia 10/2017
1	Vomiting 10/2017
1	Nausea 10/2017
1	Chromothripsis 09/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2017
1	Multiple Myeloma 09/2017
1	Deafness (Deaf Mutism) 01/2017
1	Blindness (Hysterical Blindness) 01/2017
1	Obesity 01/2017

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 02/2024 - 05/2009
5	Cell-Free Nucleic AcidsIBA 04/2019 - 05/2009
4	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 03/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2016
4	Gemcitabine FDA Link 10/2017 - 08/2011
3	Sorafenib (BAY 43-9006)FDA Link 12/2021 - 04/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 03/2003
2	trilostane FDA Link 01/2022 - 01/2021
2	Circulating Tumor DNAIBA 12/2021 - 10/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2019
2	MelatoninIBA 01/2019 - 01/2016
2	CarcinogensIBA 01/2019 - 04/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2017 - 12/2016
2	Vincristine (Oncovin)FDA LinkGeneric 11/2017 - 12/2016
2	Rituximab (Mabthera)FDA Link 11/2017 - 12/2016
2	Prednisone (Sone)FDA LinkGeneric 11/2017 - 12/2016
2	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 08/2011
2	NucleotidesIBA 09/2017 - 04/2016
2	Histones (Histone)IBA 04/2016 - 09/2007
2	ErbB Receptors (EGF Receptor)IBA 11/2011 - 03/2010
2	Gefitinib (Iressa)FDA Link 08/2011 - 07/2011
2	Codon (Codons)IBA 07/2011 - 02/2002
2	AntigensIBA 03/2011 - 06/2008
1	sotorasibIBA 02/2024
1	Canertinib (CI 1033)IBA 01/2022
1	toceranib phosphateIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 12/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2021
1	Mitogen-Activated Protein KinasesIBA 08/2021
1	VemurafenibIBA 08/2021
1	Phosphotransferases (Kinase)IBA 08/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Clopidogrel (Plavix)FDA Link 01/2021
1	Formaldehyde (Formol)FDA Link 11/2019
1	Histone-Lysine N-MethyltransferaseIBA 11/2019
1	ParaffinIBA 11/2019
1	Apoptosis Regulatory ProteinsIBA 05/2019
1	Phenobarbital (Luminal)FDA Link 05/2019
1	Estrogen ReceptorsIBA 05/2019
1	HLA-DRB1*04 antigenIBA 02/2019
1	HLA-DQA1 antigen (HLA DQA1)IBA 02/2019
1	HLA-DQB1 antigen (HLA DQB1)IBA 02/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2019
1	HLA-DRB1 Chains (HLA DRB1)IBA 02/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Decitabine FDA Link 01/2018
1	GalaninIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017
1	AlbuminsIBA 09/2017

Therapy/Procedure

8	Therapeutics 02/2023 - 08/2011
4	Drug Therapy (Chemotherapy) 01/2022 - 08/2011
2	Adjuvant Chemotherapy 01/2023 - 01/2022
1	Oral Administration 01/2022
1	Subcutaneous Injections 01/2021
1	Neoadjuvant Therapy 11/2019
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2017
1	Induction Chemotherapy 10/2017
1	Aftercare (After-Treatment) 09/2017
1	Radiotherapy 01/2017